Phlo has closed a £9m funding round, accessing additional investment to help scale the digital healthcare group.
This latest financing comes 14 months after the completion of a £10m Series A raise, and 12 months after the acquisition of the assets from a former competitor, TruePill UK.
It also follows a year of growth across multiple verticals, with the launch of new products in women’s health, weight management and on-demand prescribing.
The latest round’s lead investor was Par Equity, which made a significant investment from its recently-announced £100m venture capital fund. It was joined by Thairm Bio and Scottish Enterprise.
Read more HERE.
